Speaker Profile
Ph.D., CEO, Axbio Inc
Biography
Hui Tian is the Co-founder of Axbio Inc., a Silicon Valley-based company specializing in cutting-edge clinical diagnostics platforms. With a strong background in bioengineering and a passion for innovation, Hui has played a pivotal role in the development of Axbios advanced technologies, including fourth-generation nanopore sequencers and multiplex nucleic acid analysis systems. Under his leadership, Axbio has emerged as a leader in genetic testing, infectious disease diagnostics, pharmacogenomics, and oncology. Huis vision and expertise continue to drive advancements in precision medicine and healthcare innovation.
Talk
Axbio's Revolutionary Solutions for Precision Medicine
Discover how Axbios groundbreaking diagnostic platforms, including Bio-CMOS chips, multiplex PCR-microarrays, and nanopore sequencers, are transforming precision medicine. This talk highlights our innovative solutions for infectious disease detection, oncology, and personalized medicine, delivering high accuracy, cost-efficiency, and scalability for clinical and research applications.
Sequencing Technologies Showcase:
Axbio
Axbio Inc., specializes in cutting-edge clinical diagnostics platforms powered by Bio-CMOS chips and e-Chem sensing technologies. With innovations like fourth-generation nanopore sequencers and multiplex PCR-microarrays, Axbio delivers scalable, high-accuracy solutions for precision medicine, addressing needs in infectious disease diagnostics, oncology, genetics, and personalized healthcare.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Sequencing Technologies Showcase will provide 15-30 minute speaking opportunities for selected companies working with the latest technologies in precision medicine to highlight their contributions to the field.
